Ovid Therapeutics Inc. (OVID)
NASDAQ·Healthcare·Biotechnology
$2.56
-7.25%
Mkt Cap $502.06M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
Implied Upside
+114.8%
Consensus $5.50 vs current $2.56
NASDAQ·Healthcare·Biotechnology
$2.56
-7.25%
Mkt Cap $502.06M
Buy
4
Hold
0
Sell
0
Price Target (7 analysts)
$5.50
Range $4.00 – $7.00
+114.8%
Consensus $5.50 vs current $2.56